Cellular Dynamics to Present at Bank of America Merrill Lynch 2014 Health Care Conference
GlobeNewswire - Wed May 07, 3:46PM CDT
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that Chief Executive Officer Bob Palay will present at the Bank of America Merrill Lynch 2014 Health Care Conference to be held May 13 - 15, 2014, in Las Vegas.
Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Global Forecasts to 2020
M2 - Tue May 06, 10:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wwnrd5/stem_cell_therapy) has announced the addition of the "Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020" report to their offering. The global stem cell therapy market on the basis of the mode of treatment is segmented into allogeneic and autologous stem cell therapy. The allogeneic stem cell therapy is expected to command the largest share of the market in 2015, and is also expected to grow at a higher CAGR than autologous therapies from 2015 to 2020. Based on the therapeutic applications, the global market is segmented into eye diseases, metabolic diseases, GIT diseases, musculoskeletal disorders, immune system diseases, CNS diseases, CVS diseases, wounds and injuries, and others. A number of factors such as increasing funding from government and private organizations, growing industry focus on stem cell research, and increasing global awareness about stem cell therapies through various organizations are driving the growth of the global market. Furthermore, increasing funding for new stem cell lines, development of advanced genomic methods for stem cell analysis, and rising approvals of clinical trials for stem cells therapy are other factors that are propelling the growth of the market. Key Topics Covered: 1 INTRODUCTION 2 EXECUTIVE SUMMARY 3 MARKET DYNAMICS 4 PIPELINE ANALYSIS 5 INVESTOR NETWORK 6 GLOBAL STEM CELL THERAPY MARKET, BY MODE OF THERAPY 7 GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATIONS 8 REGULATORY LANDSCAPE 9 GLOBAL STEM CELL THERAPY MARKET, BY GEOGRAPHY 10 COMPETITIVE LANDSCAPE 11 COMPANY PROFILES Companies Mentioned: - Aastrom Biosciences Inc. - Advanced Cell Technologies, Inc. - Athersys Inc. - Celgene Corporation - Cellular Dynamics International - Cytori Therapeutics, Inc. - Fibrocell Science, Inc. - Gamida Cell Ltd. - Mesoblast Ltd. - Pluristem Therapeutics Inc. - StemCells Inc. For more information visit http://www.researchandmarkets.com/research/ww...ll_therapy
Cellular Dynamics International Reports First Quarter 2014 Financial Results
GlobeNewswire - Mon May 05, 3:41PM CDT
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today reported financial results for the three months ended March 31, 2014.
Cellular Dynamics Announces Launch of iCell(R) DopaNeurons, Neural Floor Plate-Derived Midbrain Dopaminergic Neurons
GlobeNewswire - Wed Apr 30, 7:01AM CDT
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced the launch of iCell(R) DopaNeurons, the company's neural floor plate-derived midbrain dopaminergic neurons generated from human induced pluripotent stem cells (iPSCs).
Cellular Dynamics to Host First Quarter 2014 Financial Results Webcast and Call
GlobeNewswire - Mon Apr 28, 3:30PM CDT
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that the company will host a webcast and conference call to discuss its financial results for the first quarter ended March 31, 2014.
Cellular Dynamics Announces Presentations at the SOT Annual Meeting Highlighting Use of iPSC-Derived Human Cells for Environmental Toxicology and Drug Toxicity Testing
GlobeNewswire - Fri Mar 21, 7:00AM CDT
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced scientific presentations at the Society of Toxicology's 53 Annual Meeting (SOT), March 23 to 27 in Phoenix.
Cellular Dynamics to Present at Regen Med Investor Day March 26 in New York
GlobeNewswire - Wed Mar 19, 3:30PM CDT
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that Chief Executive Officer Bob Palay will present at the 2 Annual Regen Med Investor Day to be held Wednesday, March 26, 2014, in New York City.
Cellular Dynamics International Reports Fourth Quarter and Fiscal Year 2013 Financial Results
GlobeNewswire - Mon Mar 10, 3:40PM CDT
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today reported financial results for the fourth quarter and for the fiscal year ended December 31, 2013.
Cellular Dynamics to Host Fourth Quarter and Full Year 2013 Financial Results Webcast and Call
GlobeNewswire - Tue Feb 25, 3:30PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that the company will host a webcast and conference call to discuss its financial results for the fourth quarter and for the fiscal year ended December 31, 2013.
Cellular Dynamics to Present at the Cowen Group's 34th Annual Health Care Conference
GlobeNewswire - Mon Feb 24, 3:49PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the Cowen Group's 34 Annual Health Care Conference at 3:30 p.m. EST, Monday, March 3, in Boston.
Cellular Dynamics International, Inc.Corporate Event Announcement Notice
Wall Street Horizon - Wed Feb 19, 8:07PM CST
Airline announces new flights in Alberta and Saskatchewan
Cellular Dynamics to Present at Leerink Swann Global Healthcare Conference
GlobeNewswire - Thu Feb 06, 3:30PM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the Leerink Swann Global Healthcare Conference at 3:30 p.m. EST, Wednesday, February 12, in New York City.
Nasdaq stocks posting largest percentage decreases
AP - Tue Jan 21, 12:56PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives
ACCESSWIRE - Mon Jan 13, 9:09AM CST
Thanks to new legislation being approved by the Upper House of Japan's Parliament in November, Japan's so-called "drug lag," specifically with respect to regenerative medicine, will likely become a thing of the past. By retooling the framework of the regulatory process for regenerative medicine products, the nation has shifted from a global drug development laggard to one of the most proactive countries on the planet aiming to safely expedite growth in the burgeoning, yet volatile, stem cell industry to meet the needs of a rapidly expanding aging population. The new laws are designed to promote innovation and could provide a clear channel to rapid commercialization that will benefit industry-leading companies like Cellular Dynamics International, Inc. (NASDAQ: ICEL), Athersys, Inc. (NASDAQ: ATHX) and Cytori Therapeutics, Inc. (NASDAQ: CYTX).
Cellular Dynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire - Fri Jan 10, 7:00AM CST
Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the 32 Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PST, Tuesday, January 14, at the Westin St. Francis Hotel in San Francisco.
Why You Must Watch Nestlé SA, Cellular Dynamics International Inc., AstraZeneca plc (ADR), and Arthr
Leo Sun, The Motley Fool - Motley Fool - Wed Jan 08, 6:58AM CST
Follow @leokornsun // full story)
Cellular Dynamics International to supply iCell and MyCell Products to NIHS for nutritional research
M2 - Wed Jan 08, 5:17AM CST
Stem cell technologies company Cellular Dynamics International (NasdaqGM:ICEL) revealed on Wednesday the execution of long-term supply agreement with the Nestle Institute of Health Sciences SA (NIHS) for an undisclosed amount.
Cellular Dynamics Signs Agreement With Nestle Institute of Health Sciences to Supply iCell(R) and MyCell(R) Products for Nutritional Research
Thomson Reuters ONE - Wed Jan 08, 1:00AM CST
MADISON, Wis., Jan. 8, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced signing a long-term supply agreement with the Nestle Institute of Health Sciences SA (NIHS). Terms of the agreement were not disclosed.
Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 16, 7:05AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 23, 2013.